Refactored intracellular domains enhance CAR expression and function

Chimeric antigen receptor (CAR) intracellular domains (ICDs) couple antigen recognition to T-cell activation. Here we worked with AI agents to refactor CAR ICDs, proposing designs and refining them as measurements accumulated over three rounds. This approach yielded KRGR-ζ1-40, a 45-amino-acid ICD less than a third the length of the clinical 4-1BB-CD3ζ (BBζ) ICD. Compared with BBζ, KRGR-ζ1-40 increased CAR surface expression and antigen-driven IFN-γ release, without detectable antigen-independent IFN-γ release. KRGR-ζ1-40 extended CAR expression and target-cell killing after transient mRNA delivery, supported the expression of four CARs from a shared mRNA dose, and enhanced B-cell depletion after lentiviral and lipid-nanoparticle delivery. These results show that iterative agent-guided design with experimental feedback can yield compact ICDs that enhance CAR expression and sustain CAR T-cell function.

Authors

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-10-29
DOI
https://doi.org/10.64898/2026.10.28.762481
Primary Topic
CAR-T cell therapy research
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
preprint

Refactored intracellular domains enhance CAR expression and function

Liam Bai, Gevorg Grigoryan, Hetvi J. Desai, Jason Yi et al.
3 links
bioRxiv (Cold Spring Harbor Laboratory)
CAR-T cell therapy research
preprint

Refactored intracellular domains enhance CAR expression and function

Liam Bai, Gevorg Grigoryan, Hetvi J. Desai, Jason Yi, Dinesh P. de Alwis, Daria J. Hazuda, Wujie Wang, Aakriti Kumar, Jiahe Li
preprint en

Abstract

Chimeric antigen receptor (CAR) intracellular domains (ICDs) couple antigen recognition to T-cell activation. Here we worked with AI agents to refactor CAR ICDs, proposing designs and refining them as measurements accumulated over three rounds. This approach yielded KRGR-ζ1-40, a 45-amino-acid ICD less than a third the length of the clinical 4-1BB-CD3ζ (BBζ) ICD. Compared with BBζ, KRGR-ζ1-40 increased CAR surface expression and antigen-driven IFN-γ release, without detectable antigen-independent IFN-γ release. KRGR-ζ1-40 extended CAR expression and target-cell killing after transient mRNA delivery, supported the expression of four CARs from a shared mRNA dose, and enhanced B-cell depletion after lentiviral and lipid-nanoparticle delivery. These results show that iterative agent-guided design with experimental feedback can yield compact ICDs that enhance CAR expression and sustain CAR T-cell function.

bioRxiv (Cold Spring Harbor Laboratory)
Good health and well-being
CAR-T cell therapy research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon